相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis
Feng Liu et al.
HEPATOLOGY (2020)
High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease
Roberta Forlano et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Stephen A. Harrison et al.
JOURNAL OF HEPATOLOGY (2020)
Artificial intelligence as the next step towards precision pathology
B. Acs et al.
JOURNAL OF INTERNAL MEDICINE (2020)
Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials
Beth A. Davison et al.
JOURNAL OF HEPATOLOGY (2020)
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
Zobair Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Rates of and Factors Associated With Placebo Response in Trials of Pharmacotherapies for Nonalcoholic Steatohepatitis: Systematic Review and Meta-analysis
Ma Ai Thanda Han et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Refining Sample-Size Estimations Based Upon Placebo Response in Trials of Agents for Nonalcoholic Fatty Liver Disease
Veeral Ajmera et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials
Arun J. Sanyal et al.
HEPATOLOGY (2019)
Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology
Kaustav Bera et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Statistical Aspects of Wasserstein Distances
Victor M. Panaretos et al.
ANNUAL REVIEW OF STATISTICS AND ITS APPLICATION, VOL 6 (2019)
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Chris Estes et al.
HEPATOLOGY (2018)
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
Chris Estes et al.
JOURNAL OF HEPATOLOGY (2018)
Combining dependent P-values with an empirical adaptation of Brown's method
William Poole et al.
BIOINFORMATICS (2016)
Automatic quantification of lobular inflammation and hepatocyte ballooning in nonalcoholic fatty liver disease liver biopsies
Scott Vanderbeck et al.
HUMAN PATHOLOGY (2015)
Automatic classification of white regions in liver biopsies by supervised machine Learning
Scott Vanderbeck et al.
HUMAN PATHOLOGY (2014)
The Enhanced Liver Fibrosis (ELF) score: Normal values, influence factors and proposed cut-off values
Ralf Lichtinghagen et al.
JOURNAL OF HEPATOLOGY (2013)
Placebo in Nonalcoholic Steatohepatitis: Insight Into Natural History and Implications for Future Clinical Trials
Rohit Loomba et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Grading and staging systems for inflammation and fibrosis in chronic liver diseases
Zachary D. Goodman
JOURNAL OF HEPATOLOGY (2007)
Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease
Raphael B. Merriman et al.
HEPATOLOGY (2006)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Statistical significance for genomewide studies
JD Storey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
